MedservRegis p.l.c. (MSE:MDS)
Malta · Delayed Price · Currency is EUR 0.6900
0.00 (0.00%)
At close: Jun 18, 2026
MedservRegis p.l.c. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 104.61 | 70.01 | 73.93 | 66.94 | 29.92 | |
Revenue Growth | 49.42% | -5.30% | 10.44% | 123.69% | 165.14% |
Cost of Revenue | 74.33 | 50.35 | 54.53 | 52.78 | 22.55 |
Gross Profit | 30.27 | 19.66 | 19.4 | 14.16 | 7.37 |
Selling, General & Admin | 18.44 | 13.87 | 13.21 | 13.07 | 8.9 |
Other Operating Expenses | -0.3 | -0.19 | -0.25 | - | - |
Operating Expenses | 18.77 | 13.27 | 12.2 | 13.54 | 9.34 |
Operating Income | 11.51 | 6.39 | 7.2 | 0.63 | -1.97 |
Interest Expense | -4.43 | -4.19 | -4.19 | -4.02 | -2.14 |
Interest & Investment Income | 0.9 | 0.52 | 1.09 | 0.34 | 0.06 |
Earnings From Equity Investments | - | - | - | - | 0.03 |
Currency Exchange Gain (Loss) | -0.5 | 0.97 | -2.76 | 7.3 | 3.96 |
EBT Excluding Unusual Items | 7.48 | 3.68 | 1.34 | 4.26 | -0.05 |
Impairment of Goodwill | - | - | - | -0.37 | -1.03 |
Gain (Loss) on Sale of Investments | 0.17 | 0.2 | 0.44 | -1.11 | 0.31 |
Gain (Loss) on Sale of Assets | -0.06 | 0.14 | -0.03 | -0.33 | -0.39 |
Asset Writedown | -0.09 | -0.15 | -0.08 | -2.29 | -6.2 |
Other Unusual Items | 0.02 | - | - | -0.14 | - |
Pretax Income | 7.52 | 3.87 | 1.67 | 0.02 | -7.36 |
Income Tax Expense | 2.02 | 1.77 | 0.38 | -0.52 | -0.06 |
Earnings From Continuing Operations | 5.5 | 2.1 | 1.29 | 0.54 | -7.3 |
Earnings From Discontinued Operations | - | - | - | - | 0.1 |
Net Income to Company | 5.5 | 2.1 | 1.29 | 0.54 | -7.2 |
Minority Interest in Earnings | -0.32 | -0.23 | -0.21 | 0.03 | -0.31 |
Net Income | 5.18 | 1.87 | 1.08 | 0.58 | -7.51 |
Net Income to Common | 5.18 | 1.87 | 1.08 | 0.58 | -7.51 |
Net Income Growth | 177.74% | 72.63% | 87.23% | - | - |
Shares Outstanding (Basic) | 102 | 102 | 102 | 102 | 53 |
Shares Outstanding (Diluted) | 102 | 102 | 102 | 102 | 53 |
Shares Change | - | - | - | 90.17% | -52.36% |
EPS (Basic) | 0.05 | 0.02 | 0.01 | 0.01 | -0.14 |
EPS (Diluted) | 0.05 | 0.02 | 0.01 | 0.01 | -0.14 |
EPS Growth | 177.75% | 72.63% | 87.25% | - | - |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 9.44 | 12.52 | 9.72 | 17.04 | 1.54 |
Free Cash Flow Per Share | 0.09 | 0.12 | 0.10 | 0.17 | 0.03 |
Dividend Per Share | 0.025 | 0.025 | - | - | - |
Dividend Growth | 0% | - | - | - | - |
Gross Margin | 28.94% | 28.08% | 26.24% | 21.16% | 24.64% |
Operating Margin | 11.00% | 9.12% | 9.74% | 0.93% | -6.57% |
Profit Margin | 4.96% | 2.67% | 1.46% | 0.86% | -25.10% |
Free Cash Flow Margin | 9.02% | 17.88% | 13.15% | 25.45% | 5.14% |
EBITDA | 16.49 | 11.54 | 12.78 | 6.66 | 1.83 |
EBITDA Margin | 15.76% | 16.48% | 17.28% | 9.94% | 6.12% |
D&A For EBITDA | 4.98 | 5.15 | 5.58 | 6.03 | 3.8 |
EBIT | 11.51 | 6.39 | 7.2 | 0.63 | -1.97 |
EBIT Margin | 11.00% | 9.12% | 9.74% | 0.93% | -6.57% |
Effective Tax Rate | 26.81% | 45.85% | 22.58% | - | - |